title: Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders.
abstract: Lithium has been the most effective psychopharmacological drug in the long-term treatment of patients with recurrent unipolar and bipolar affective illness. As a result of its widespread and longtime use in patients with recurrent affective disorders, psychiatrists have become increasingly aware of the whole spectrum of lithium's potential side effects. One of the side effects associated with its chronic use is lithium-induced nephropathy. In a recent cross-sectional study published in BMC Medicine, Alberto Bocchetta et al. add further information to this topic, demonstrating that duration of lithium treatment is associated with impaired glomerular function in patients with recurrent or chronic affective disorders. The present paper will discuss the implications of this and other related recent research on our management of patients with recurrent affective disorders. In this context the importance of shared decision making and close monitoring of kidney function is highlighted, including the regular assessment of the glomerular filtration rate, to provide best possible care to our patients maintained on lithium treatment.See related research article here http://www.biomedcentral.com/1741-7015/11/33.
authors: Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstr, 74, D-01307 Dresden, Germany. Emanuel.Severus@uniklinikum-dresden.de
authors: Emanuel
authors: E
authors: Severus
authors: Michael
authors: M
authors: Bauer
mesh_terms: D005260:Female; D006801:Humans; D007678:Kidney Glomerulus / Q000187:drug effects*; D008094:Lithium / Q000008:administration & dosage* / Q000009:adverse effects*; D008297:Male; D011619:Psychotropic Drugs / Q000008:administration & dosage* / Q000009:adverse effects*; D051437:Renal Insufficiency / Q000139:chemically induced*
chemical_list: D011619:Psychotropic Drugs; D008094:Lithium
references: Lancet. 2012 Feb 25;379(9817):721-8
references: 22265699
references: BMC Med. 2012 Nov 02;10:132
references: 23121772
references: Nat Rev Nephrol. 2009 May;5(5):270-6
references: 19384328
references: Kidney Int. 2003 Aug;64(2):585-92
references: 12846754
references: J Affect Disord. 2010 Nov;126(3):436-40
references: 20483164
references: Nephrol Dial Transplant. 2008 Feb;23(2):562-5
references: 17999992
references: BMC Med. 2013 Feb 11;11:33
references: 23399351
references: Br J Psychiatry. 2008 Aug;193(2):93-5
references: 18669987
references: Kidney Int. 2011 Jul;80(1):17-28
references: 21150873
references: Nervenarzt. 2012 May;83(5):568-86
references: 22576049
references: J Clin Psychiatry. 2010 Sep;71(9):1153-7
references: 20923621